Amersham Sues PerkinElmer Over Drug Technology Patents

Law360, New York (October 24, 2003, 12:00 AM EDT) -- Amersham Biosciences and its parent, U.K.-based Amersham PLC, have filed a lawsuit in the U.S. District Court in Newark, NJ, against PerkinElmer Inc., alleging that PerkinElmer infringed on two of Amersham's patents for technology used in the development of new drugs.

The complaint alleges that PerkinElmer's ViewLux and Image FlashPlate products infringe on Amersham patents for technologies that use luminescence and fluorescence to analyze compounds being screened for use in the development of new drugs. Amersham said PerkinElmer continues to sell those products despite being advised...
To view the full article, register now.

UK Financial Services

UK Financial Services

Read Our Latest UK Financial Services Coverage

Financial Services Law360 UK provides breaking news and analysis on the financial sector. Coverage includes UK and European Union policy, enforcement, and litigation involving banks, asset management firms, and other financial services organizations.